A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged ≥65 years with mild to moderate hypertension
- 31 October 2000
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (10) , 1213-1224
- https://doi.org/10.1016/s0149-2918(00)83064-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patientsAmerican Journal of Hypertension, 1999
- ACE Inhibitor—Versus Angiotensin II Blocker–Induced Cough and AngioedemaAnnals of Pharmacotherapy, 1998
- A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertensionJournal of Human Hypertension, 1998
- Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertension.Blood Pressure, 1998
- Candesartan CilexetilDrugs, 1998
- Effects and Tolerability of Irbesartan Versus Enalapril in Patients With Severe HypertensionThe American Journal of Cardiology, 1997
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- ValsartanDrugs, 1997
- Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertensionClinical Therapeutics, 1996
- Losartan PotassiumDrugs, 1996